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ARTICLE
Perinatal inflammation influences but does not
arrest rapid immune development in preterm
babies
S. Kamdar1, R. Hutchinson2,3, A. Laing1, F. Stacey2, K. Ansbro 3,5, M.R. Millar3, K. Costeloe3, W.G. Wade 4,
P. Fleming2,3,6 & D.L. Gibbons 1,6✉
Infection and infection-related complications are important causes of death and morbidity
following preterm birth. Despite this risk, there is limited understanding of the development
of the immune system in those born prematurely, and of how this development is influenced
by perinatal factors. Here we prospectively and longitudinally follow a cohort of babies born
before 32 weeks of gestation. We demonstrate that preterm babies, including those born
extremely prematurely (<28 weeks), are capable of rapidly acquiring some adult levels of
immune functionality, in which immune maturation occurs independently of the developing
heterogeneous microbiome. By contrast, we observe a reduced percentage of CXCL8-
producing T cells, but comparable levels of TNF-producing T cells, from babies exposed to in
utero or postnatal infection, which precedes an unstable post-natal clinical course. These data
show that rapid immune development is possible in preterm babies, but distinct identifiable
differences in functionality may predict subsequent infection mediated outcomes.
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Longitudinal data consistently show overall mortality fol-lowing preterm birth to be falling; however, among babieswho die, the proportion attributed to infection and
infection-related complication such as necrotising enterocolitis
(NEC) is fixed or increasing1,2. It is estimated that up to 30% of
preterm babies born before 32 weeks gestation develop at least
one clinical or microbiologically confirmed episode of sepsis3, but
the course of individual babies through the perinatal period is
unpredictable, some progressing smoothly while others succumb
to multiple pathologies, including late-onset sepsis and NEC.
There is a clinical need both to identify around the time of
birth those preterm infants most likely to develop infective
complications and to develop therapies to prevent and ameliorate
infection in this vulnerable group, ideally through promoting the
baby’s own immune capabilities. Understanding the development
of the immune system in the healthy preterm infant, how it
differs in those with complicated courses and how it is modified
by peri- and postnatal factors is fundamental to these aims.
Furthermore, not only are these issues acutely relevant to the
infant, but increasing evidence suggests that the nature of the
infant immune response in early life, where rapid immune
development has been observed4,5, may profoundly influence
later susceptibility to immune mediated diseases6,7. Thus, infants
born before 32 weeks gestational age (GA) show a greater sus-
ceptibility to asthma in later life and yet a decreased risk of
developing food allergy8,9.
Despite these drivers, understanding of how the preterm
immune system develops is incomplete, and the impacts on the
developing immune system of exposure to infection in utero, as
well as the postnatal clinical course, have not been comprehen-
sively evaluated.
It is increasingly acknowledged that the preterm immune
system is not just an immature version of the adult, but is both
qualitatively and quantitatively distinct with overt functional
potentials10. To address how the immune system develops in
those born prematurely, we prospectively and longitudinally
follow a cohort of preterm babies born before 32 weeks gestation
and compare their immune function for up to 3 months post
birth. We demonstrate that preterm babies (even those born at
the earliest gestation) rapidly acquire some adult levels of
immune function; have immune functions that progress towards
but do not reach adult levels; or have immune functions, con-
spicuously C-X-C motif chemokine ligand 8 (CXCL8)-producing
T cells, that remain significantly distinct from adults. Babies born
at an earlier GA show immune profiles that change more dra-
matically when compared to those born at later gestations, thus
reducing any negative impact of extreme prematurity. Immune
development occurs independently of specific changes within the
developing microbiome, suggesting that other factors may have a
greater bearing on immune development in the first few months
of life. A defining feature of those infants who develop infection is
a lower level of CXCL8-producing T cells initially, thus identi-
fying a potential biomarker for identifying infants at greater risk
of sepsis. This, in turn, may help reduce the burden posed by
infection and lead to improved outcomes for babies born
prematurely.
Results
Patient demographic and clinical characteristics. Thirty-nine
babies with a median gestation of 28.7 weeks (range 23.6–31.7)
and a mean (SD) birthweight of 1060 g (383) enrolled between
January 2016 and December 2017 were assessed. Participant
demographic and clinical data are provided in Table 1. Ten babies
were classified as stable (receiving a single course of antibiotics in
the immediate postnatal period) and 16 were unstable, having
received additional courses of antibiotics for suspected late-onset
sepsis or other infection concerns including NEC. Thirteen fur-
ther infants were born to mothers with histological or clinically
confirmed chorioamnionitis, all but one of these also fulfilled the
unstable criteria. Of note, babies in the stable group were gen-
erally born at later gestation, had higher birth weights and all
were delivered by caesarean section.
Postnatal immune development in all babies. One hundred and
eighty-six different peripheral blood immune populations were
analysed, with and without in vitro stimulation, using 11-colour
flow cytometry panels. Samples were taken longitudinally (mean
of eight samples per baby) from the infant cohort until discharge
from the neonatal intensive care unit (NICU) or until 36 weeks
post-menstrual age. The sampling regime, analysis pipeline and
clinical groupings are depicted in Fig. 1. Initially, we identified
immune parameters that were most distinct between adults and
preterm infants within the first few days of birth (Supplementary
Fig. 1). Unsurprisingly, CXCL8 (a cytokine known to be pivotal in
this demographic10) was one of the most divergent parameters,
significantly elevated in infants compared to adults.
Changes in immune parameters over time. We then studied any
alterations in these immune parameters over time. To address
which parameters changed most significantly with postnatal age,
we compared the regression coefficients of each parameter in each
baby and plotted the mean value in relation to how different they
were from adult at initial sampling (Fig. 2a). Over half of all
parameters studied showed significant changes in this time per-
iod. Many parameters that were reduced around birth (anything
below the half way line on y-axis) increased (and hence appeared
in lower right-hand quadrant), and conversely those that were
elevated in the first sample taken from the neonate (anything
above the half way line on y-axis) decreased towards adult levels
—located in the upper left-hand quadrant. Conspicuously,
although CXCL8-producing natural killer (NK) and γδ cells that
were initially elevated subsequently decreased with time, this was
not true for CXCL8-producing CD4 and CD8 T cells of various
phenotypes. These populations started elevated compared to
adults and remained so, highlighting their potential functional
importance in the neonatal immune response.
Parameters that increased over time included B cells, which
increased in both percentage (Fig. 2b) and absolute number
(Supplementary Fig. 2a); NK cells that increased in both
percentage (Fig. 2c) and absolute number (Supplementary
Fig. 2b); γδ T cells (Supplementary Fig. 2c); HLADR expression
on monocytes (Fig. 2d and Supplementary Fig. 2d); and NKG2D
expression on NK cells (Fig. 2e). Consistent with the observation
that the CD4:CD8 ratio is much greater in (term) neonates than
adults11, the percent representation of CD8+ T cells increased
over time coincident with an increase in their absolute number
(Supplementary Fig. 2e, f). CD161 expression on CD8 T cells
decreased in the 3-month study period (Fig. 2f).
With respect to changes in functionality that occurred
postnatally (determined by assessing cytokine production follow-
ing in vitro stimulation with phorbol myristate acetate and
ionomycin), we observed significantly increased percentages of
interferon-γ (IFN-γ)-producing NK cells (Fig. 2g) and γδ T cells
(Fig. 2h and Supplementary Fig. 3a). However, levels of IFN-γ-
producing CD4 T cells in these babies remained extremely low
even at 3 months of age and there was no reproducible increase in
the capacity of CD4 T cells to produce IFN-γ over time (Fig. 2i
and Supplementary Fig. 3b). CD4 T cells continued to produce
CXCL8, however, and the levels did not diminish towards that
seen in adult in the time frame studied (Fig. 2j). We observed that
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the time to blood processing did have an adverse effect on
cytokine production. Nevertheless, when we assessed any
relationship between processing time and the sample age
(considering we are assessing changes in parameters over time)
there was none, further highlighting our data that suggest that the
development of immune parameters is related to postnatal age
Effect of extreme prematurity. To identify whether the con-
sensus pattern of immune development that we observed in our
infant cohort also occurred in the event of extreme prematurity,
we performed principal component analysis (PCA) analyses using
all the flow cytometry parameters to generate immune profiles for
each baby at each time point. By comparing the immune profile
generated in the first week of life compared to that generated at
around 5 weeks of age, we observed that the babies’ immune
profiles progressed in a similar direction as they aged (Fig. 3a).
Importantly, this trajectory was generally followed by all the
babies, independent of the infant’s GA at birth. In fact, when we
examined distance travelled along this trajectory, babies born at
the earliest GA tended to exhibit a greater degree of movement
over a similar time period to those born at later GAs (Fig. 3b). t-
Distributed stochastic neighbour embedding analyses suggested
that even though all babies progressed down this shared devel-
opmental pathway, samples taken from the same baby (repre-
sented by individual colours) appeared to retain unique features
sufficient to cluster samples most closely according to their
individual profile. This differentiation of babies one from another
was sustained throughout their time in the NICU (Fig. 3c). Due to
ethical considerations around obtaining detailed longitudinal
samples from term infants, we were unable to assess inter-
individual immune profile heterogeneity in a term infant cohort.
We were, however, able to demonstrate a similar trajectory in
immune parameters in samples obtained from different term
infants (n= 6) taken at different postnatal ages (up to 3 months)
despite their inherent heterogeneity. Functionality (as assessed by
cytokine production) increased in γδ T cells in both term and
preterm cohorts, whereas both cohorts failed to show a repro-
ducible increase in the ability of CD4 T cells to produce IFN-γ.
This suggests that postnatal adaptation may be similar, irrelevant
of GA at birth and that many immune parameters develop after
birth. Whereas the general direction of immune development was
mirrored in the preterm and term infants, there were some
exceptions, notably CD161 expression on CD8 T cells. The per-
centage of CXCL8-producing CD4 T cells also appeared to
decrease faster in those born at term compared to those born
prematurely (Supplementary Fig. 4a).
Associations between immune parameters. To identify any
immune cell populations that may associate with each other
(either positively or negatively) in our infant cohort, we per-
formed Spearman’s correlation coefficients (R ≥ 0.3 or R ≤−0.3)
across our whole data set. We identified significant associations
(p < 0.008) between several immune parameters. These associa-
tions were grouped into nodes based on cell type (see Fig. 3d).
Table 1 Participant demographic and clinical data.
Total babies (n= 39) Stable babies (n= 10) Unstable babies (n= 16) Chorioamnionitis (BCM, n= 13)
Gestation, median 28.7 (23.6–31.7) 30.5 (29.1–31.7) 28 (23.6–31.7) 25.7 (24–30.1)
Birthweight, mean 1060 g (383) 1366 g (242) 1062 g (422) 821 g (241)
Sex
Male 23 (59%) 6 (60%) 11 (69%) 6 (46%)
Female 16 (41%) 4 (40%) 5 (31%) 7 (54%)
Multiple births
Singleton 29 (73%) 5 (50%) 11 (69%) 13 (100%)
Multiple 10 (27%) 5 (50%) 5 (31%)
Apgar 5 min, median 9 (2–10) 10 (6–10) 9 (2–10) 9 (2–10)
Maternal ethnicity
White 9 (23%) 1 (10%) 4 (25%) 4 (31%)
Black 20 (51%) 4 (40%) 10 (63%) 6 (46%)
Asian 7 (18%) 4 (40%) 1 (6%) 2 (15%)
Other 3 (8%) 1 (10%) 1 (6%) 1 (8%)
Antenatal steroids
Any 36 (92%) 10 (100%) 13 (81%) 13 (100%)
>24 h before delivery 18 (46%) 6 (60%) 7 (44%) 5 (38%)
None 3 (8%) 0 (0%) 3 (19%) 0 (0%)
Delivery by caesarean
Yes 24 (62%) 10 (100%) 12 (75%) 2 (15%)
No 15 (38%) 0 (0%) 4 (25%) 11 (85%)
Chorioamnionitis 13 (33%) 0 (0%) 0 (0%) 13 (100%)
Histologically confirmed 12 (31%) 12 (92%)
Antenatal antibiotic administration 11 (28%) 4 (40%) 2 (12%) 5 (38%)
Microbiologically confirmed sepsis (any episode) 14/39 (36%) 0 (0%) 7 (44%) 7 (54%)
Days antibiotics, median, range 15 (3–51) 4 (3–7) 19 (5–51) 19 (5–35)
Suspected GI pathology (including NEC)a 7/39 (18%) 0 (0%) 5 (31%) 2 (15%)
NEC Bell’s stage II or > 3/39 (7%) 0 (0%) 3 (19%) 0 (0%)
Days to full enteral feedsb 14 (7–42) 12 (7–37) 16.5 (8–33) 15 (7–42)
Received any maternal breast milk 37/39 (95%) 10 (100%) 14 (87.5%) 13 (100%)
Abnormalities on CrUSS
IVHc 6 (15%) 1 (10%) 2 (12.5%) 3 (23%)
HPI 2 (5%) 0 1 (6%) 1 (8%)
PVL 3 (8%) 0 1 (6%) 2 (15%)
Chronic lung diseased 14 (36%) 0 (0%) 8 (50%) 6 (46%)
ROPe 16 (10%) 1 (10%) 8 (50%) 7 (54%)
Data are presented as means (standard deviation); medians (ranges); n= number and percentages.
CRUSS cranial ultrasound, IVH intraventricular haemorrhage, HPI haemorrhagic parenchymal infarction, PVL periventricular leukomalacia, CLD chronic lung disease, ROP retinopathy of prematurity.
aSuspected GI pathology is defined as ‘any abdominal concerns necessitating nil by mouth for more than 5 days’.
bFull enteral feeds defined as ‘the first day on which 100% of fluid volume was administered enterally’.
cIVH is defined as ‘bleeding contained within and not extending beyond the ventricular system’.
dCLD is defined as ‘the need for supplemental oxygen at 36 weeks post-menstrual age’.
eROP is defined as ‘any stage ROP recorded on formal eye examination’.
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Some populations (e.g. intermediate monocytes) showed no
correlation with others and were subsequently lost from this
network analysis. Due to the linked nature of flow cytometry, we
only used one parameter (of a correlated pair) in the analysis to
avoid correlations due to experimental technique. Examples of
unanticipated positive correlations included the expression of
CD161 on γδ T cells correlating with their production of IFN-γ
(R= 0.5) and between IFN-γ-producing (CXCL8−) γδ and CD8
T cells (R= 0.41) (Fig. 3e). There was also a good correlation
between CXCL8-producing CD4 and CD8 T cells (R= 0.62)
(Fig. 3e). Similar correlations were also observed in term babies
(n= 9) under 6 months of age (Supplementary Fig. 4b).
Potential sources controlling immune profile variation. There
were extensive differences identified between the neonatal pre-
term infant and the equivalent adult immune profile. However,
while some immune parameters exhibited rapid maturation over
the time frame of our study, even in those infants born extremely
preterm, others showed little change. Considering the links pre-
viously suggested between immune cell development, immune
homeostasis, and the microbiome12, we considered the develop-
ing intestinal microbiome as a potential driver of these changes in
immune profile. Similarly, many immune parameters are sexually
dimorphic, at least in mice13. Hence, we also considered the
influence of sex on these developing immune profiles.
Stool microbiome analyses were performed on 10 stable infants
(100% of eligible cohort); 13 unstable infants (81% of eligible
cohort); and 11 infants born to mothers with chorioamnionitis
(85% of eligible cohort). Initially, we analysed the development of
the microbiome by assessing the range of different taxa that
appeared in faeces over time (longitudinal development of
diversity). In the stable group, microbiome diversity increased
at a rate of 0.56 U per week (95% confidence interval: 0.3–0.9).
Conversely, there was significantly restricted growth in diversity
in both the unstable (median 0.035 vs. 0.56 U per week, p <
0.0001) and the chorioamnionitis group (0.053 vs. 0.56, p <
0.0001), with no significant difference in the rate of diversity
progression between these cohorts (Fig. 4a).
When assessing the emergence of taxa in our cohort, the family
Enterobacteriaceae was the dominant family across all the groups.
Figure 4b shows representative examples of taxa progression in
individual babies from the three clinical classifications. When the
longitudinal progression of Enterobacteriaceae was compared
between the groups, Enterobacteriaceae relative abundance fell
much quicker in the stable cohort (median 5.6% per week) than
either the unstable (−5.6 vs. 0.16, p= 0.04) or the chorioamnio-
nitis groups (−5.6 vs. 0.38, p= 0.06) (Fig. 4c).
As Enterobacteriaceae relative abundance fell in the stable
cohort, a shift towards higher proportions of other families was
observed. The next most prevalent were Veillonellaceae (which
gradually increased over time) and Bifidobacteriaceae (which
increased from ~day 30) having a maximum relative abundance
of >1% in 9/10 and 10/10 infants, respectively (Supplementary
Fig. 5). Conversely, Staphylococcaceae were highly prevalent (>1%
maximum abundance in 8/10 participants) in early life, becoming
almost absent beyond day 20. Other notable families (Clostridia-
ceae 8/10; Enterococcaceae 9/10) changed minimally over time,
and generally maintained low median abundances. In the
unstable groups, these consistent patterns of microbial commu-
nity progression were not observed (Supplementary Fig. 5),
although a strikingly decreased prevalence of Bifidobacteriaceae
was noted (46% of unstable infants were never colonised with
Bifidobacteriaceae, that is, never had a relative abundance in any
sample >1%).
We then analysed the microbiome structure in conjunction
with the immune parameters. Each microbiome profile was
compared to each immune profile in individual babies and the
data combined to identify any significant correlations across the
34 infants on which both sets of data were available. We could
identify very few correlations between the two data sets
(Supplementary Fig. 6). The only weak association identified
was between Staphylococcaceae and myeloid dendritic cells (DCs).
To establish additional factors driving the different immune
profiles in our preterm infant cohort, we analysed for
differences driven by sex. Perhaps surprisingly, the majority
of immune parameters showed no significant sexual dimorph-
ism, but there were three notable exceptions. Both CD31 and
CD38 expression on CD4 T cells were significantly elevated in
female infants compared to their male counterparts (Supple-
mentary Fig. 7a, b). In contrast, CD161 expression on CD8
T cells was higher in males and then subsequently decreased
(2) CLINICAL CLASSIFICATION POST SAMPLE COLLECTION: 3 GROUPS
(1) SAMPLE PROCESSING AND COLLECTION
Baby reaches 36
weeks post-
menstrual age
Flow
cytometry
Baby stable for
discharge home
500 μl blood sample taken
weekly and at times of
suspected infection
Stool samples taken
when available
16S rRNA gene NGS
23 + 4 to 31 + 6 weeks GA at birth
written informed consent was
obtained from 62% of the eligible
cohort
(1) STABLE
Abx immediately
after birth only
no evidence of
chorioamnionitis
n = 10
(2) UNSTABLE
Repeated Abx treatment
no evidence of
chorioamnionitis
n = 16
(3) BCM
Evidence of
chorioamnionitis
n = 13
Immune profile 182
cell subsets
23
Microbiome
analysis16
Fig. 1 Schematic representing study design.Written informed consent was obtained from parents before 72 h of age and of the parents approached, 62%
agreed to enter the study as described in the figure.
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more dramatically in expression over time than in females
(Supplementary Fig. 7c).
In utero and postnatal exposure to inflammation. Having
shown limited associations between immune parameters and sex/
microbiome, we considered the effects of both pre- and postnatal
exposure to infection on the developing immune system. Ana-
lyses of the whole immune profiles by PCA for the different
clinical groups described in Table 1 identified distinct immune
signatures in babies who had experienced different pre- and
postnatal exposures to the stable infants (Fig. 5a, b). Babies who
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had an unstable course or those born in the context of chor-
ioamnionitis showed elevated levels of the activation marker
CD69 on all T cell populations (CD4, CD8 and γδ) as well as on
NK cells (Fig. 5c–f) when compared to babies who had a stable
postnatal course. CD35 (also known to increase upon cell acti-
vation) was also elevated on both CD4 and CD8 T cells, sig-
nificantly so in those infants exposed to chorioamnionitis
(Supplementary Fig. 8a). There was no difference in CD25
expression, however, on either CD4 or CD8 T cells between the
different clinical groups.
Stable infants exhibited low levels of proliferation initially
(<10% of CD4 T cells were Ki67 positive in the first blood
sample). However, there was a consistent proliferative burst (to
nearly a quarter of CD4 T cells) around 2 weeks after birth, which
rapidly returned to post birth levels, seen in nearly all infants
(Fig. 5g). Elevated CD4 T cell proliferation was also observed
immediately post birth in infants born to mothers with
chorioamnionitis (Fig. 5g). Similarly, elevated levels of inter-
mediate monocytes, particularly in the immediate postnatal
period, were seen in babies born to mothers with chorioamnio-
nitis (p= 0.0004, Fig. 5h), both suggestive of in utero activation.
However, levels of HLADR expression on these perinatal
monocytes were significantly lower than that seen in stable
infants (Supplementary Fig. 8b). FOXP3 expression was sig-
nificantly reduced on T-regs isolated from infants born to
mothers with chorioamnionitis (Fig. 5i). CD8 expression was
maintained on γδ T cells (both Vδ1 and Vδ2) in unstable infants
compared to those with a stable clinical course (where levels
decreased rapidly post birth, Fig. 5j, k).
To identify any changes in functionality between the different
clinical groups, cytokine production following in vitro stimulation
with phorbol myristate acetate and ionomycin was assessed. The
ability of CD4 T cells to produce tumour necrosis factor (TNF)
and interleukin-2 (IL-2) (Fig. 6a, b) upon in vitro stimulation was
indistinguishable between the three clinical groups, yet, in
contrast, the ability to produce CXCL8 was severely and
significantly reduced in both the chorioamnionitis and unstable
groups when compared to stable infants (Fig. 6c). It has been
previously suggested that the capacity of T cells to produce TNF
and CXCL8 was reciprocally regulated based on GA14. However,
we did not see significant changes in the capacity of CD4 T cells
to make TNF or CXCL8 based on their GA at birth in this cohort
(Supplementary Fig. 9a, b). Similarly, babies born at the same GA
exhibited very different percentages of T cells with the capability
to produce either CXCL8 or TNF (Supplementary Fig. 9c, d). In
every case, despite an equivalent GA at birth, those babies
exhibiting the lowest levels of CXCL8-producing T cells (but not
TNF-producing T cells) were those infants with an unstable
clinical course (Supplementary Fig. 9c, d). Furthermore, when we
separated bacteraemias into those from coagulase-negative
staphylococci (CoNS) vs. other bacteria (as CoNS infections
generally have lower morbidity and mortality rates), those infants
demonstrating the lowest initial levels of CXCL8-producing
T cells were those that subsequently developed the more severe
(non-CoNS) infections. This was despite an equivalent capacity to
produce TNF or IL-2 (Fig. 6d–f). When compared to stable
infants, significantly lower CXCL8-producing CD4 T cells were
seen in infants with clinically suspected sepsis3 (n= 16, p=
0.007) and in those infants with microbiologically confirmed
sepsis caused by either coagulase CoNS (n= 9, p= 0.039) or
other bacteria (n= 4, p= 0.0007) such as Group B streptococcus,
Escherichia coli or Streptococcus anginosus.
Discussion
The consequences of preterm birth on immune development and
function are not well established15. In this study, we demonstrate
that preterm babies, even those born at 23 and 24 weeks gestation,
were capable of rapidly acquiring several components of immune
function. The immune profiles for babies born at earlier gesta-
tions changed more dramatically over a similar time period to
those born at later gestations, which suggests that extremely
preterm babies are capable of rapid progression to ‘catch up’
immune function. This corroborates data suggesting that the
immune profiles of preterm and term babies converge in a similar
time frame4 and that rapid immune development in term babies
follows a set trajectory5. Despite inherent heterogeneity in
immune parameters between individuals, longitudinal changes in
immune function were observed both in our preterm cohort and
in different infants born at term and sampled at different ages
during the postnatal period. This suggests similar postnatal
adaptation in both cohorts. However, despite this immune
development, some of the preterm babies developed infection.
Strikingly, this was associated with a reduced T cell capacity to
produce CXCL8, highlighting the CXCL8 pathway as a potential
therapeutic target for preventing infection in preterm babies. The
interpretation of our data is however constrained by the lack of an
equivalent longitudinal data set from a cohort of healthy full-term
infants to which to compare our findings. In our experience, no
research ethics committee would sanction such extensive sam-
pling in healthy term babies to the same degree of sampling that
we have conducted in patients recruited to our study. To address
this, we, like others, have analysed samples obtained opportu-
nistically from hospitalised infants, in our case awaiting cardiac
surgery; the normality of which can be challenged.
Immune development in these preterm infants occurred
apparently independently of changes within the developing
intestinal microbiome. Prolonged broad-spectrum antibiotic
Fig. 2 Phenotypic and functional maturation of distinct immune parameters. Longitudinal PBMC samples from 39 preterm babies were phenotyped for
186 different immune populations by flow cytometry following surface and intracellular staining. For cytokine detection, samples were activated in vitro
with PI (4 h, in the presence of BFA) prior to staining. a Postnatal Immune cell trajectories relative to their deviation from the first infant sample taken,
compared with adult levels. Position along y-axis indicates deviation from adult (the log 2 fold difference) in the first sample; position along x-axis indicates
whether the population has increased or decreased significantly in the infant over time. Thus, immune populations in the top left quadrant start higher than
adult levels and then decrease over time towards the adult level. Populations in the bottom right start below adult levels and increase over time towards
that of the adult. Colour indicates—log 10 p value (Wilcoxon’s matched-pairs signed-rank test) for correlation with age with large circles indicating CXCL8-
producing cell types. Among the CXCL8-producing populations, the red outline indicates NK and γδ T cells, whereas the blue outline CD4 or CD8 αβ
T cells. b–j Changes in individual immune parameters over time depicted by scatter plots showing frequencies/MFI (as indicated) in preterm babies (left
panel; cyan circles) as a function of postnatal age compared to adults (right panel; black circles). b CD19+ B cells, c HLADR MFI in classical monocytes,
d NK cells, e NKG2D+ NK cells, f CD161+ CD8 T cells, g IFN-γ+ NK cells, h IFN-γ+ γδ T cells, i IFN-γ+ CD4 T cells, and j CXCL8+ CD4 T cells. In the figure,
cyan circles represent a pool of longitudinal samples from 39 preterm babies where each circle represents an individual sample and on average there are
eight longitudinal samples per baby. Black circles are a pool of samples from nine adults. ***p < 0.001, **p < 0.01, and *p < 0.05 as determined by linear
mixed-effect modelling using the lmer package in R. Source data are provided as a Source Data file.
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treatment of the unstable infants likely transformed the devel-
oping microbiome and yet those infants were still capable of
immune maturation along the established trajectory. Given the
generally naive nature of the neonatal immune system, it is
conceivable that exposure to any environmental stimulus is suf-
ficient to drive the observed maturation of the immune system
during this period. Indeed, the sudden increase in proliferation of
CD4 T cells and other T cells, which we observed at around
2 weeks of age, may be related to microbial colonisation. Rapid
intestinal colonisation with a range of organisms would most
likely far eclipse any differences driven by specific individual
colonisers. Alternatively, microbial–immune relationships may
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exist below family level. Similarly, although the stable infants
showed some consistency in stool microbial profiles with
decreased Enterobacteriacae over time, these were replaced by a
variety of different obligate anaerobes.
While the mode of birth has been associated with the devel-
opment of specific microbiomes16, we were unable to dissociate
mode of birth from other exposures as all stable (but not all
unstable) infants in our cohort were born by caesarean section.
The observed association of high Staphylococcaceae abundance in
early life in the stable group (uniformly born by operative
delivery) is consistent with the previously noted association of
staphylococci colonisation after caesarean section (as opposed to
natural birth)17,18. Indeed, the only (weak) association of the
microbiome with the immune parameters was a negative asso-
ciation between Staphylococcaceae abundance and myeloid DCs, a
proportion of which could be driven by age. Similarly, while
breast-feeding (either wholly or partially) is also known to sig-
nificantly influence microbiome development19, almost all babies
received at least some maternal breast milk.
Aspects of both innate and adaptive immunity developed
rapidly during the period of study. B cells increased in numbers
after birth as did γδ T cells whose function (as determined by IFN-
γ production) was enhanced over time, both in those born pre-
maturely or at term. We identified a decrease in CD8 expression
on γδ T cells, but interestingly, only in stable preterm babies. This
suggests either clonal expansion of an existing CD8+ population
and/or increased CD8 expression upon activation in those infants
experiencing episodes of infection. It is intriguing that we
see significant changes in the γδ T cell population in our cohort as
we and others have suggested these cells are of particular
importance in providing protection to infants in early life20–22.
In contrast, αβ CD4 T cells showed scant, if any, development over
this time period, in both term and preterm cohorts. There was
little change in their ability to produce CXCL8, which, if anything,
increased over the time frame in those born prematurely while
decreasing slightly in those born at term, presumably as a result of
different levels of T cell export from the thymus23,24 and they were
still unable to produce IFN-γ upon ex vivo stimulation. This
relative inability to produce IFN-γ may be related to hyper-
methylation of the IFN-γ promoter previously observed in human
newborn infants25. Although we did not see any significant
increase in IFN-γ-producing CD8 T cells over postnatal age,
there was a significant association between IFN-γ-producing γδ
T cells and IFN-γ-producing CD8 T cells, suggesting some
maturation in the latter, albeit at a slower rate than that observed
for γδ T cells.
In this study, an individual baby’s subsequent clinical course
could not have been predicted at the time of birth. Babies with an
unstable postnatal clinical course and those born in the context of
chorioamnionitis both succumbed to higher rates of micro-
biologically confirmed sepsis and chronic lung disease when
compared to the stable cohort. Our data highlight the influence of
both the in utero environment and the postnatal clinical course
on the developing immune profiles of preterm infants. Bacteria
implicated in chorioamnionitis (such as E. coli) have also been
shown to produce histone-modifying enzymes to down-regulate
protein expression and there is increasing evidence that sepsis can
induce epigenetic changes that alter immune responses26,27. We
cannot exclude the potential confounder of GA in our data set as
all of the stable babies were born at a later GA. This notwith-
standing, many of the parameters that differed between the
clinical groups seemed less likely to be related to GA as opposed
to clinical state. Furthermore, if we plotted all our parameters
based on postmenstrual age, the graphs were more or less iden-
tical. Hence, an activated immune profile straight after birth, as
suggested by several parameters (e.g. expression of CD69, CD35
and proliferation) and previously observed28, was seen in infants
born to mothers with chorioamnionitis. Furthermore, sig-
nificantly elevated intermediate monocytes were also observed in
this group. This is despite the fact that these cells are particularly
sensitive to delays in blood processing, suggesting that this may
be an under-representation of the true levels. However, although
they increased in number, their functional potentials may be poor
as we identified significantly reduced HLADR expression on these
cells, as has also been observed previously29. Indeed, monocytes
developing in the context of chorioamnionitis have shown
hyporesponsiveness to different stimuli29,30, perhaps explaining
the increased susceptibility to early-onset sepsis observed in this
patient group31. Similarly, those infants born to mothers with
chorioamnionitis also exhibited significantly lower levels of
FOXP3 expression in T-regs, suggesting reduced functionality32.
Sex is known to have a significant bearing on neonatal out-
comes with male preterm infants experiencing more adverse
outcomes than females33, and yet we saw very few significant
differences in immune parameters between male and female
infants. The few immune differences that were identified may,
therefore, be functionally relevant. Both CD31 and its binding
partner, CD38, were significantly lower in male CD4 T cells
compared to their female counterparts, suggesting the whole
pathway may be less efficient. Interestingly, CD38 has been
shown to enhance T cell (and NK) activation by contributing to
immune synapse formation34,35 and CD31-deficient mice show
Fig. 3 Development of whole immune profiles and correlations. Longitudinal PBMC samples were phenotyped by flow cytometry as described.
a, b Analyses of the immune parameters from 39 preterm babies shows that the immune profile of extremely preterm babies (lighter colour) travels a
longer distance, but on the same trajectory compared to their less preterm counterparts (darker colour) as depicted by: a PCA of the immune profile of
samples taken in the first week (small circle, mean= 3.8 days) compared to that of the sample taken 5 weeks later (large circle, mean= 37 days) for each
baby. The colour gradient represents how many days preterm the baby was at birth (counting down from 40 weeks). Each circle represents a sample from
an individual baby and the size represents postnatal age of the baby at sampling. Lines link individual babies. b Scatter plot quantifying the Euclidian
distance moved in PC1 and PC2 for each baby. The colour gradient represents how many days preterm the baby was at birth. Each symbol represents an
individual baby. c t-Distributed stochastic neighbour embedding (tSNE) analysis of the immune parameters shows that babies have their own individual
profile. Each circle represents a sample from an individual baby (the size of the circle depicts the postnatal age of the baby when the sample was taken) and
each colour represents longitudinal samples from the same baby. d Network represents statistically significant (p < 0.008) Spearman’s correlation
coefficients (R ≥ 0.3 or R ≤−0.3) between immune parameters. Each node represents an immune parameter. Nodes are grouped by lineage and coloured
by function; node size relates to the number of relationships. If any parameters were inherently related to other parameters due to the nature of flow
analysis, only one parameter (of a correlated pair) was used in the correlation plot. e Plots depicting correlation between frequency of (left panel) IFN-γ+
γδ T cells and CD161-expressing γδ T cells; (middle panel) IFN-γ+ CXCL8− CD8 T cells and IFN-γ+ γδ T cells; and (right panel) CXCL8-producing CD4 and
CD8 T cells. The data shown are a pool of longitudinal samples from 39 preterm babies, where each circle represents an individual sample and on average
there are eight longitudinal samples per baby. Individual babies are in different colours. Source data are provided as a Source Data file.
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enhanced susceptibility to LPS-induced endotoxic shock36. The
only other factor that appeared to be sexually dimorphic was
CD161 expression on CD8 T cells, which decreased in both male
and female infants postnatally (albeit from an increased starting
level in males). The expression of CD161 is thought to evoke a
particular functional profile37 irrelevant of the cell type. It is
interesting, therefore, that expression was enhanced postnatally
on NK cells and γδ T cells (where it correlated with IFN-γ pro-
duction), but decreased on CD8 T cells. It is possible that some
CD161+ CD8+ T cells represent mucosal-associated invariant T
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(MAIT) cells and thus the rapid decrease may be associated with
migration out of the blood into the intestine. Interestingly, this
decrease was not seen in the term infants, suggesting that, as
opposed to the majority of parameters assessed, this may be
dependent on GA, and gut homing of MAIT cells may take place
prior to term birth.
The principal effector chemokine of neonatal CD4 T cells is
CXCL810. CXCL8 expression was highly divergent between
infants and adults, and there was a strong correlation between
CXCL8-producing CD4 and CD8 T cells in our babies, regardless
of GA at birth. Levels of CXCL8-producing αβ T cells did not
significantly decrease towards adult levels over the time period
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studied, despite reductions in CXCL8-producing NK and γδ
T cells. This notwithstanding, infants born in the context of
chorioamnionitis or those with an unstable clinical course
exhibited significantly lower CXCL8-producing CD4 and CD8
T cells when compared to stable infants. There may be several
reasons for this observation. It is possible that these cells are
somehow exhausted in the unstable cohorts. This is unlikely to be
the case as the ability of the same cells to produce TNF or IL-2
was not reduced. Furthermore, both infection and inflammation
may themselves be implicated. In this study, we show that babies
born in the context of chorioamnionitis (inflammation) and those
with repeated episodes of infection have lower CXCL8 responses
but we do not know the mechanisms that link this association.
The observation that CXCL8 and TNF production may be reci-
procally associated with GA14 and that unstable infants in this
cohort were generally born at an earlier GA, may also be an
explanation. However, amongst this cohort, there appeared to be
no correlation between GA and the ability of CD4 T cells to
produce CXCL8 or TNF around birth. Nevertheless, a reduced
number of CXCL8-producing T cells was consistently observed in
those infants with an unstable clinical course who were more
likely to develop serious postnatal complications. This inability to
mount adequate T cell CXCL8 responses in the first few days of
life (for whatever reason) may therefore predict a poor outcome.
This finding may have particular clinical relevance, both identi-
fying CXCL8 as a potential therapeutic target but also as a bio-
marker to predict subsequent outcomes for babies born
prematurely.
Methods
Ethical approval and funding. Funding was granted by Barts Charity (Ref: 764/
2306) for the undertaking of a study named ‘Investigating Microbial Colonisation
and Immune Conditioning in Preterm Babies’. Ethical and regulatory approvals
were granted by the London (Chelsea) Research Ethics Committee (Ref: 15/LO/
1924) and the local Research and Development department at Homerton Uni-
versity Hospital NHS Foundation Trust. Term infant blood samples were collected
with informed consent as part of the Infectious Disease Biobank, ethical approval
granted by South Central—Hampshire B Research Ethics Committee (Ref: 09/
H0504/39) from infants undergoing cardiac surgery. Written informed consent was
obtained in every case.
Participant enrolment. Participants were recruited from the neonatal intensive
care unit at Homerton University Hospital between January 2016 and December
2017. Babies born between 23 weeks and 4 days and 31 weeks and 6 days of
gestation admitted to the NICU before 72 h postnatal age, including those born at
other hospitals, were included in this study. Of those participants eligible for
recruitment, 22% were not approached as they were thought to have no realistic
chance of survival, had known exposure to either HIV or hepatitis B infection or
due to other concerns, including capacity to provide consent and availability of the
research team. Written informed consent was obtained from parents before 72 h of
age, and of the parents approached, 62% agreed to participate.
Sample collection and storage. Blood samples (0.5 ml whole blood) from preterm
infants were collected on a weekly basis, with additional samples taken at times of
suspected infection, up to cessation of the infants’ participation. Blood samples
(0.5 ml whole blood) from term infants were collected prior to cardiac surgery. All
samples were collected opportunistically during routine sampling for clinical
indications (as mandated by the Ethics Review Committee) and were stored at
room temperature (on average for 12 h and up to a maximum of 30 h) prior to
Ficoll separation of peripheral blood mononuclear cells (PBMCs), and were frozen
in Cryostore (Sigma) and stored in liquid nitrogen. Faecal samples were collected
on a daily basis (when available) from birth up to cessation of the infants’ parti-
cipation in the study (i.e. discharge or transfer). Samples were immediately stored
at 4 °C for <72h, before transferring to long-term storage at −80 °C.
Clinical data. Detailed demographic, antenatal and daily postnatal data were
collected prospectively on all preterm infants. Once each subject completed their
hospital stay, their clinical course was reviewed by the clinical team and the par-
ticipants classified a priori into one of three clinical cohorts:
● All infants born to mothers with a history of clinical or histologically
confirmed chorioamnionitis
● Stable infants—those infants receiving a single course of antibiotics only in the
immediate postnatal period, with no episodes of suspected late-onset sepsis or
antibiotic exposure thereafter
● Unstable infants—those infants who did not meet the stable criteria, having
received additional courses of antibiotics for suspected late-onset sepsis or
other infection concerns including NEC.
The collaborating immunology team was not aware of the clinical status of
babies when blood samples were collected and/or analysed. Once the laboratory
analyses were completed, the participants’ clinical courses were provided by the
clinical team. No clinical data (other than GA at birth, postnatal age (<6 months)
and the fact they were undergoing cardiac surgery for non-immune-related
conditions) were collected on the term infants.
Cell stimulation. PBMCs were stimulated with phorbol myristate acetate and
ionomycin as described below. Cells were stimulated in RPMI-1640 medium
(Invitrogen) containing 10% (vol/vol) FCS (StemCell Technologies), 2 mM L-glu-
tamine (Sigma), 100 U penicillin and 100 μg/ml streptomycin (Invitrogen) (com-
plete medium, CM) containing 10 ng/ml phorbol 12-myristate 13-acetate (Sigma)
and 1 μg/ml ionomycin (Sigma) for 4 h at 37 °C, 5% CO2 in the presence of 20 μg/
ml brefeldin A (Sigma). For spontaneous cytokine production, cells were incubated
in CM in the presence of brefeldin A only.
Flow cytometry. All samples from individual babies were analysed simultaneously
to avoid introducing any unnecessary experimental variation. Single-cell suspen-
sions were prepared in FACS buffer (phosphate-buffered saline plus 2.5% (vol/vol)
foetal calf serum and 2mM EDTA) and then split into nine aliquots for staining
with nine different 11-colour flow cytometry panels. To one of the aliquots, 50 μl of
Countbright Absolute counting beads (catalogue no. C36950, Life Technologies)
was added. Initially, cells were incubated on ice for 15 min with Zombie NIR Fixable
Viability Kit (BioLegend) to allow live/dead discrimination. For panels containing
Vδ1, the surface staining antibody was added along with the live/dead dis-
crimination stain. Cells were then surface stained on ice for 30 min with antibodies
listed in Supplementary Table 1. Following surface staining, cells were fixed (Cell
Fix, BD) and then permeabilised using Perm buffer (BioLegend). For panels con-
taining transcription factor FoxP3, cells were fixed and permeablilised using fixation
and permeabilising reagents from Invitrogen’s Intracellular Fixation & Permeabi-
lisation Buffer Set (catalogue no. 88-8824-00) according to the manufacturer’s
instructions. Following permeabilisation, cells were then intracellulary stained for
Fig. 5 Immune parameters altered by different pre- and/or postnatal exposures. Longitudinal PBMC samples from 39 preterm babies were phenotyped
for 186 different immune populations by flow cytometry following surface and intracellular staining. For cytokine detection, samples were activated in vitro
with PI (4 h, in the presence of BFA) prior to staining. PCA of 186 immune parameters from longitudinal samples derived from: a stable (grey circles; n= 10
babies) and unstable (blue circles, n= 16) babies. b Stable (grey circles; n= 10) and BCM (red circles, n= 13) babies. In c–f, scatter plots depict
frequencies of CD69+ cells in stable babies (left panel; grey circles, n= 10), unstable babies (middle panel; blue circles, n= 16) and BCM babies (right
panel; red circles, n= 13) as a function of postnatal age: c CD69+ CD4 T cells, d CD69+ CD8 T cells, e CD69+ γδ T cells, f CD69+ NK cells are depicted
from the three clinical groups. g Proliferation (as depicted by the boxplot showing frequency of Ki67 expression in CD4+ T cells) was elevated immediately
post birth in infants born to mothers with chorioamnionitis, whereas stable (and to a lesser extent unstable) infants showed a proliferative burst at around
14 days of age. In this box-and-whisker plot, horizontal bars indicate the median, boxes indicate 25th to 75th percentile, and whiskers indicate 10th and
90th percentile. Compared to stable babies, unstable and BCM babies show significantly higher frequencies of intermediate monocytes (h) and
significantly lower FOXP3 MFI in Tregs (i) and higher frequencies of CD8α-expressing γδ T cells over time in both j Vδ1+ γδ T cells and k Vδ2+ γδ T cells.
Data shown are a pool of longitudinal samples from each clinical group where on average there are eight samples per baby in the stable cohort (n= 10) and
nine samples per baby in the unstable cohort (n= 16) and the BCM cohort (n= 13). For all figures except g, ***p < 0.001, **p < 0.01 and *p < 0.05 as
determined by linear mixed-effect modelling using the lmer package in R. For g, **p < 0.01 and *p < 0.05 as determined by a non-parametric Wilcoxon’s
matched-pairs signed-rank test. Source data are provided as a Source Data file.
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Fig. 6 Unstable infants have significantly reduced CXCL8-producing T cells compared to stable babies. Longitudinal PBMC samples from 39 preterm
babies were activated in vitro with PI (4 h, in the presence of BFA) and expression of CXCL8, TNF and IL-2 assessed by flow cytometry. Scatter plots
showing frequencies of a TNF, b IL-2 and c CXCL8 in stable babies (left panel; grey circles, n= 10), unstable babies (middle panel; blue circles, n= 16) and
BCM babies (right panel; red circles, n= 13) as a function of postnatal age. In a–c, data shown are a pool of longitudinal samples from each clinical group
where each circle represents a longitudinal sample from an individual baby and on average there are six samples per baby in the stable cohort and nine
samples per baby in the unstable cohort and the BCM cohort. Blood culture-positive bacteraemias were separated into those from coagulase-negative
staphylococci (CoNS) and other bacteria as CoNS infections are generally considered to be less severe with lower mortality rates. Scatter plots showing the
frequencies of d CXCL8, e TNF and f IL-2 in stable babies (far left panel; grey circles, n= 10 babies with a mean of eight longitudinal samples per baby),
babies with microbiologically confirmed infections (second panel; n= 4 with a mean of 11 longitudinal samples per baby), babies with coagulase-negative
staphylococcal infections (CoNS) (third panel, n= 9 with a mean of 10 longitudinal samples per baby) and babies with suspected infections (far right panel;
n= 16 with mean of seven longitudinal samples per baby). The colour of the circles depicts the type of infection as described in the figure. In d–f, each
circle represents a longitudinal sample from an individual baby and linked circles represent longitudinal samples from the same baby. ***p < 0.001, **p <
0.01 and *p < 0.05 as determined by linear mixed-effect modelling using the lmer package in R. Source data are provided as a Source Data file.
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cytokines and transcription factor FOXP3 with antibodies listed in Supplementary
Table 1. All samples were run on a four laser BD LSRFortessa X20 flow cytometer.
To minimise the impact of temporal variation in instrument sensitivity, cytometer
performance was monitored using CS+T beads (BD) and experiments were run
using applications settings. Data were analysed using the FlowJo software. All gating
strategies utilised are shown in Supplementary Figs. 10–15.
Laboratory methodology for faecal DNA extraction. Faecal samples were
selected for analysis on a pragmatic basis to provide regularity of assessment
throughout the infants’ admissions, with increased resolution at times of clinical
instability, and subject to availability—samples were selected approximately every
3 days (where possible), with additional samples taken before/during/after courses
of antibiotics, feeding type changes, ventilation changes, and blood transfusions, to
capture possible associated microbiome changes.
Faecal bacterial DNA was extracted using the DNeasy® PowerSoil® Kit (Qiagen,
Netherlands), following treatment with propidium monoazide, to prevent
downstream amplification of contaminant or non-viable free bacterial DNA. The
V4 hypervariable region of the 16S rRNA gene was amplified using PCR with a
dual-indexing strategy, and sequencing of the subsequent amplicons was
performed using Illumina MiSeq technology (2 × 250 bp flow cell for paired-end
sequencing with 5% PhiX DNA).
Faecal microbiome analysis. Sequencing data were processed using the DADA2
pipeline and all analyses and graphics were produced by means of R packages
(DADA2, decontam, tidyr, dplyr, ggplot2 and mblm)38–44. Microbiome analyses
were performed on 10 stable (100% of eligible participants), 13 unstable (81%) and
11 chorioamnionitis (84%) infants.
Biometrics of microbiome structure were used to describe the development of
bacterial communities within the cohort: for the description of constituent taxa,
analysis was performed at the family level, as this represented the lowest taxonomic
level with the highest level of read identification (99.9% of amplicons were
identified at family level; only 74% were identified at genus level); only those taxa
with a mean relative abundance of >1% across all samples were included in the
analyses. Diversity was estimated using the inverse Simpson statistic, and was
derived from all taxa (regardless of relative abundance). The longitudinal
progression of the relative abundances of individual family-level taxa were
described.
Statistical analysis. Difference between neonatal and adult immune profiles: To
understand the degree to which the immune profile of neonates differed from that
of adults, we performed a two-tailed non-parametric Wilcoxon’s rank-sum test
with a Benjamini–Hochberg correction for multiple comparisons between adult
samples (n= 9) and the first time point neonatal blood sample for each individual
(n= 33).
Longitudinally changing data sets. To identify immune parameters that changed
significantly over time, longitudinal models of the cell-subset frequencies and total
numbers at the group level were constructed. Group level slopes were estimated
using mixed linear models of the cellular frequencies/numbers versus postnatal age,
with a random intercept and slope at an individual level (LME4 R package)45. The
regression lines were weighted by the number of samples per baby, which varied
between infants. To determine whether a given immune parameter changed sig-
nificantly between one time point and another, a non-parametric Wilcoxon’s
matched-pairs signed-rank test was used.
To assess the longitudinal development of microbial communities over time,
regression coefficients (Theil–Sen non-parametric regression coefficient) for
diversity and Enterobacteriaceae relative abundance against time were calculated as
summary measures to describe the longitudinal progression of individual
participants. These summary measures were then used to derive group level
summary statistics (i.e. median), and to allow statistical comparison between the
groups (by weighted Mann–Whitney U test). Summary measures were weighted to
account for the number of originating data points (corresponding to numbers of
samples) from which the individual measures were derived. Only the family
Enterobacteriaceae was examined in this manner, as it was the only taxon widely
distributed across the data set in significant relative abundances (>40% mean
abundance in >90% of all participants) to allow comparison between the three
clinical groups. Longitudinal progression of individual taxa in the three clinical
cohorts is represented by a plot of relative abundance of individual taxa at each
time point. In recognition of the bimodal distribution of some taxa, we highlighted
the infants who were essentially not colonised with specific taxa at any time point
(maximum relative abundance <1%).
To understand the relationships that exist between immune parameters and
microbiome parameters, intra-individual Spearman’s correlation was performed.
To account for variation in the sampling schedule between blood and stool, we
binned the data into 5-day time windows to match blood and contemporaneous
stool samples. In the event of more than one sample per individual occurring in
any given bin, mean values were calculated for every parameter measured.
Spearman’s correlation analyses were performed across all parameters barring
those directly linked to one another owing to the nested nature of flow cytometry
analysis (e.g. in the case of CD4 and CD8 as a percentage of total αβ T cells, only
CD4 T cells are represented in the analysis). A mean value was derived for the
correlation coefficient between all parameters across all individuals. For a
relationship to be considered significant, it would have to consistently yield a p
value of <0.2 in every individual tested, the aggregate of this across all individuals
equates to a p value threshold of p= 0.008. Stool passage was unpredictable among
babies recruited to the study, so not all infants had sufficient samples to perform a
100% match between immunological and microbiome parameters.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The flow cytometry data (FCS files) has been deposited in Flow Repository (http://
flowrepository.org/id/FR-FCM-Z2FJ). The 16S rRNA gene sequence data has been
deposited onto NCBI BioProject accession reference PRJNA605031.
Code availability
We did not use any custom code. The code packages used are listed here: DADA2,
decontam, ggplot2, mblm, dplyr, tidyr, lme4, Viridis, ViridisLite, data.table,
Rcolorbrewer, ggrepel, ggfortify, ggbeeswarm and reshape2, gridExtra, Hmisc, Rtsne and
corrplot.
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